Paolo Pucci

Insider Reports History

Location
Burlington, MA
Signature
/s/ Peter Silverman as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paolo Pucci:

Company Role Class Num Shares Value Price $ Report Date Ownership
WEST PHARMACEUTICAL SERVICES INC Director Common Stock 10,947 $2,205,482 $201.47 06 May 2025 Direct
Merus N.V. Director Share Option (right to buy) 0 $119,571 $13.52 12 Dec 2025 Direct
Replimune Group, Inc. Director Stock Option (right to buy) 32,000 01 Apr 2025 Direct
Trillium Therapeutics Inc. Director Stock Option (Right to Buy) 0 17 Nov 2021 Direct

Insider Reports Filed by Paolo Pucci

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MRUS Merus N.V. 12 Dec 2025 6 $0 4 Director 12 Dec 2025, 18:56
MRUS Merus N.V. 22 May 2025 1 $0 4 Director 27 May 2025, 08:00
WST WEST PHARMACEUTICAL SERVICES INC 06 May 2025 1 $0 4 Director 08 May 2025, 17:00
REPL Replimune Group, Inc. 01 Apr 2025 1 $0 4 Director 03 Apr 2025, 20:05
MRUS Merus N.V. 07 May 2024 1 $0 4 Director 09 May 2024, 16:30
WST WEST PHARMACEUTICAL SERVICES INC 23 Apr 2024 1 $0 4 Director 25 Apr 2024, 16:55
REPL Replimune Group, Inc. 01 Apr 2024 1 $0 4 Director 03 Apr 2024, 20:02
MRUS Merus N.V. 08 Jun 2023 1 $0 4 Director 12 Jun 2023, 16:16
WST WEST PHARMACEUTICAL SERVICES INC 25 Apr 2023 1 $0 4 Director 27 Apr 2023, 17:17
REPL Replimune Group, Inc. 01 Apr 2023 1 $0 4 Director 04 Apr 2023, 20:04
MRUS Merus N.V. 31 May 2022 1 $0 4 Director 02 Jun 2022, 16:05
WST WEST PHARMACEUTICAL SERVICES INC 24 May 2022 1 $0 4 Director 26 May 2022, 15:49
REPL Replimune Group, Inc. 01 Apr 2022 1 $0 4 Director 05 Apr 2022, 16:09
/report/000110465921141751-pucci-paolo-2021-11-17 Trillium Therapeutics Inc. 17 Nov 2021 1 $0 4 Director 19 Nov 2021, 12:33
MRUS Merus N.V. 28 May 2021 1 $0 4 Director 02 Jun 2021, 16:10